DTSOF yields 7.70% · PFE yields 6.20%● Live data
📍 DTSOF pulled ahead of the other in Year 1
Combined, DTSOF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DTSOF + PFE for your $10,000?
DTS Corporation provides systems integration services in Japan. The company operates through four segments: Finance and Society; Corporate Solutions; Operational Infrastructure BPO; and Regional, Overseas, Etc. It develops and maintains information systems; designs and constructs electrical and telecommunications construction work related to information systems; develops, sells, and leases educational equipment and teaching materials related to the information systems; and publishes, edits, and translates work related to the information systems. The company also installs, operates, and maintains computer systems and networks; manufactures, develops, sells, and leases information related equipment comprising computers and software; processes and provides information and commercial transactions; produces, sells, and leases multimedia related content; and acquires, develops, licenses, manages, and transfers intellectual property, such as copyrights and know-how. In addition, it engages in worker dispatch business; and contracting for planning, investigating, researching, training, educating, and consulting activities related to information systems. Further, the company offers enterprise resource planning solutions; and network integration services. It serves finance, telecommunications, and public sector comprising medical welfare, pension authorities, and local governments. DTS Corporation was incorporated in 1972 and is headquartered in Tokyo, Japan.
Full DTSOF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.